Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Sotiros GeorgeVP - INFORMATION SYSTEMS |  WEYSWEYCO GROUP INCOption exercise | M | $22K 780 sh | Aug 10, 2026 |
| 9 | Stellato StevenSee Remarks |  KNTKKinetik Holdings Inc.Grant or award | A | — 10.8K sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner |  BLSMBlossomHill Therapeutics, Inc.Derivative conversion | C | — 1.60M sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Grant or award | A | — 112.7K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 1.60M sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Daffey Michael DDirector |  GLXYGalaxy Digital Inc.Grant or award | A | — 7,866 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 124.8K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Price Dwayne PChief Accounting Officer |  OPLNOPENLANE, Inc.Tax withholding | F | $4,659 126 sh | Aug 10, 2026 traded Aug 9, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 113.4K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 1.60M sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Holmes Joseph R.VP & Chief Accounting Officer |  TMOTHERMO FISHER SCIENTIFIC INC.Option exercise | M | — 420 sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Oxnard Geoffrey RaymondChief Medical Officer | BLSMBlossomHill Therapeutics, Inc. Grant or award | A | — 61.8K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Agrawal SundeepDirector | BLSMBlossomHill Therapeutics, Inc. Grant or award | A | — 23.9K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Masino Julie D.Director, CEO |  CBRLCRACKER BARREL OLD COUNTRY STORE, INCTax withholding | F | $40K 688 sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Behan MarkDirector |  AROWARROW FINANCIAL CORPOption exercise | M | — 773 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Wall MatthewSee Remarks | KNTKKinetik Holdings Inc. Grant or award | A | — 12.2K sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Sotiros GeorgeVP - INFORMATION SYSTEMS | WEYSWEYCO GROUP INC Option exercise | M | $22K 1,200 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Lee TaeCFO |  PLTKPlaytika Holding Corp.Tax withholding | F | $3,649 1,241 sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Rottinghaus Scott T.Chief Medical Officer |  ENTAENANTA PHARMACEUTICALS INCTax withholding | F | $20K 1,467 sh | Aug 10, 2026 traded Aug 8, 2026 |
| 9 | Lyskawa NancyEVP & Chief Client Officer |  RMNIRimini Street, Inc.Grant or award | A | — 25.0K sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | McIntosh Greg WEVP, Chief Commercial Officer |  IRMIRON MOUNTAIN INCOption exercise · 10b5-1 plan | M | $253K 6,839 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Sotiros GeorgeVP - INFORMATION SYSTEMS | WEYSWEYCO GROUP INC Option exercise | M | $29K 1,200 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 124.8K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Ofek Amir YechielDirector |  GILTGILAT SATELLITE NETWORKS LTDOption exercise | M | — 8,334 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 124.8K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 124.8K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Koutsouras BillDirector | GLXYGalaxy Digital Inc. Grant or award | A | — 7,866 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Sotiros GeorgeVP - INFORMATION SYSTEMS | WEYSWEYCO GROUP INC Option exercise | M | $20K 780 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Liptak Vincent PaulGeneral Counsel | BLSMBlossomHill Therapeutics, Inc. Grant or award | A | — 46.6K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Sandison JonathanCFO, Vroom and UACC |  VRMVroom, Inc.Grant or award | A | — 30.0K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Combs Michael GCEO & President |  CRVLCORVEL CORPGrant or award | A | — 1,500 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Li YishanDirector, Executive Chairman, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 113.4K sh | Aug 10, 2026 traded Aug 10, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Grant or award | A | — 676.2K sh | Aug 10, 2026 traded Aug 6, 2026 |
| 9 | Regan Michael EdwardDirector |  PFSPROVIDENT FINANCIAL SERVICES INCGrant or award | A | — 3,066 sh | Aug 10, 2026 traded Aug 7, 2026 |
| 9 | Cui Jingrong JeanDirector, President and CEO, 10% Owner | BLSMBlossomHill Therapeutics, Inc. Derivative conversion | C | — 1.60M sh | Aug 10, 2026 traded Aug 10, 2026 |
| 8 | Slessor MikeDirector, CEO |  FORMFORMFACTOR INCTax withholding | F | $386K 3,288 sh | Aug 10, 2026 traded Aug 7, 2026 |
| 7 | Britt Christopher RDirector, Chief Executive Officer |  CHYMChime Financial, Inc.Derivative conversion · 10b5-1 plan | C | — 49.8K sh | Aug 10, 2026 traded Aug 7, 2026 |
| 7 | Sanders A ShaneDirector |  CVLTCOMMVAULT SYSTEMS INCGrant or award · 10b5-1 plan | A | — 1,761 sh | Aug 10, 2026 traded Aug 6, 2026 |
| 6 | Agarwal DeveshChief Operating Officer | BANDBandwidth Inc. Option exercise | M | — 7,370 sh | Aug 10, 2026 traded Aug 8, 2026 |
| 6 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer |  GWREGuidewire Software, Inc.Open-market sale · 10b5-1 plan | SELL | $203K 1,200 sh | Aug 10, 2026 traded Aug 10, 2026 |